Aspira Women's Health (AWH) Stock Forecast, Price Target & Predictions
AWH Stock Forecast
Aspira Women's Health stock forecast is as follows: an average price target of $3.30 (represents a 285.33% upside from AWH’s last price of $0.86) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
AWH Price Target
The average price target for Aspira Women's Health (AWH) is $3.30 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.30 to $3.30. This represents a potential 285.33% upside from AWH's last price of $0.86.
AWH Analyst Ratings
According to 2 Wall Street analysts, Aspira Women's Health's rating consensus is 'Buy'. The analyst rating breakdown for AWH stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Aspira Women's Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 01, 2024 | Ross Osborn | Cantor Fitzgerald | $3.30 | $3.10 | 6.45% | 285.33% |
The latest Aspira Women's Health stock forecast, released on Apr 01, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $3.30, which represents a 6.45% increase from the stock price at the time of the forecast ($3.10), and a 285.33% increase from AWH last price ($0.86).
Aspira Women's Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $3.30 |
| Last Closing Price | $0.86 | $0.86 | $0.86 |
| Upside/Downside | -100.00% | -100.00% | 285.33% |
In the current month, the average price target of Aspira Women's Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aspira Women's Health's last price of $0.86. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 14, 2024 | Alliance Global Partners | Buy | Buy | Hold |
| Apr 01, 2024 | Cantor Fitzgerald | Neutral | Neutral | Hold |
Aspira Women's Health's last stock rating was published by Alliance Global Partners on Aug 14, 2024. The company gave AWH a "Buy" rating, the same as its previous rate.
Aspira Women's Health Financial Forecast
Aspira Women's Health Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $2.49M | $2.32M | $2.15M | $2.07M | $2.07M | $1.89M | $1.85M | $1.67M | $1.80M | $1.50M | $1.45M | $1.24M | $1.31M | $1.28M | $1.14M | $803.00K | $649.00K | $726.00K | $505.00K | $951.00K |
| Avg Forecast | $5.39M | $4.75M | $4.40M | $3.85M | $3.09M | $2.76M | $2.73M | $2.56M | $2.53M | $2.91M | $2.80M | $2.56M | $2.25M | $2.45M | $2.40M | $1.96M | $1.85M | $1.60M | $1.65M | $1.37M | $1.30M | $1.13M | $4.20M | $3.80M | $3.20M | $2.30M | $486.75K | $544.50K | $505.00K | $951.00K |
| High Forecast | $5.39M | $4.75M | $4.40M | $3.85M | $3.09M | $2.76M | $2.73M | $2.56M | $2.53M | $2.91M | $2.80M | $2.56M | $2.25M | $2.45M | $2.40M | $1.96M | $1.85M | $1.60M | $1.65M | $1.37M | $1.30M | $1.13M | $4.20M | $3.80M | $3.20M | $2.30M | $584.10K | $653.40K | $606.00K | $1.14M |
| Low Forecast | $5.39M | $4.75M | $4.40M | $3.85M | $3.09M | $2.76M | $2.73M | $2.56M | $2.53M | $2.91M | $2.80M | $2.56M | $2.25M | $2.45M | $2.40M | $1.96M | $1.85M | $1.60M | $1.65M | $1.37M | $1.30M | $1.13M | $4.20M | $3.80M | $3.20M | $2.30M | $389.40K | $435.60K | $404.00K | $760.80K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 8 | 8 | 8 | 8 | 10 | 10 | 20 | 10 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.91% | 0.96% | 0.85% | 0.86% | 0.97% | 1.00% | 1.04% | 1.09% | 1.09% | 1.11% | 1.10% | 0.31% | 0.34% | 0.36% | 0.35% | 1.33% | 1.33% | 1.00% | 1.00% |
Aspira Women's Health's average Quarter revenue forecast for Sep 23 based on 1 analysts is $2.91M, with a low forecast of $2.91M, and a high forecast of $2.91M. AWH's average Quarter revenue forecast represents a 16.80% increase compared to the company's last Quarter revenue of $2.49M (Jun 23).
Aspira Women's Health EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 8 | 8 | 8 | 8 | 10 | 10 | 20 | 10 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-4.32M | $-5.75M | $-6.07M | $-14.63M | $-8.16M | $-9.19M | $-8.85M | $-9.64M | $-6.99M | $-5.83M | $-5.99M | $-4.22M | $-3.33M | $-3.73M | $-4.22M | $-3.58M | $-2.65M | $-2.46M | $-4.75M | $-4.08M |
| Avg Forecast | $-5.39M | $-4.75M | $-4.40M | $-3.85M | $-3.09M | $-2.76M | $-2.73M | $-11.12M | $-2.53M | $-2.91M | $-2.80M | $-10.10M | $-2.25M | $-2.45M | $-2.40M | $-9.19M | $-1.85M | $-1.60M | $-1.65M | $-8.95M | $-1.30M | $-4.22M | $-4.20M | $-3.80M | $-3.20M | $-2.30M | $-1.99M | $-1.84M | $-4.75M | $-4.08M |
| High Forecast | $-5.39M | $-4.75M | $-4.40M | $-3.85M | $-3.09M | $-2.76M | $-2.73M | $-8.89M | $-2.53M | $-2.91M | $-2.80M | $-8.08M | $-2.25M | $-2.45M | $-2.40M | $-7.35M | $-1.85M | $-1.60M | $-1.65M | $-7.16M | $-1.30M | $-3.38M | $-4.20M | $-3.80M | $-3.20M | $-2.30M | $-1.59M | $-1.48M | $-3.80M | $-3.27M |
| Low Forecast | $-5.39M | $-4.75M | $-4.40M | $-3.85M | $-3.09M | $-2.76M | $-2.73M | $-13.34M | $-2.53M | $-2.91M | $-2.80M | $-12.13M | $-2.25M | $-2.45M | $-2.40M | $-11.02M | $-1.85M | $-1.60M | $-1.65M | $-10.74M | $-1.30M | $-5.07M | $-4.20M | $-3.80M | $-3.20M | $-2.30M | $-2.39M | $-2.21M | $-5.70M | $-4.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.54% | 0.57% | 2.70% | 5.97% | 3.40% | 1.00% | 4.78% | 6.03% | 4.24% | 0.65% | 4.60% | 1.00% | 0.79% | 0.98% | 1.32% | 1.56% | 1.33% | 1.33% | 1.00% | 1.00% |
undefined analysts predict AWH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Aspira Women's Health's previous annual EBITDA (undefined) of $NaN.
Aspira Women's Health Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 8 | 8 | 8 | 8 | 10 | 10 | 20 | 10 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-2.32M | $-6.34M | $-4.64M | $581.00K | $-8.27M | $-9.29M | $-9.01M | $-9.71M | $-7.07M | $-5.92M | $-6.08M | $-4.29M | $-3.39M | $-3.82M | $-4.31M | $-3.72M | $-2.85M | $-2.67M | $-4.90M | $-4.14M |
| Avg Forecast | $-1.82M | $-2.07M | $-2.13M | $-2.63M | $-2.75M | $-3.21M | $-3.92M | $-11.21M | $-5.59M | $-6.35M | $-6.86M | $-10.19M | $-12.38M | $-12.21M | $-13.14M | $-9.27M | $-15.02M | $-13.14M | $-11.27M | $-9.09M | $-6.89M | $-4.29M | $-3.76M | $-3.76M | $-5.63M | $-5.63M | $-2.14M | $-2.00M | $-4.90M | $-4.14M |
| High Forecast | $-1.82M | $-2.07M | $-2.13M | $-2.63M | $-2.75M | $-3.21M | $-3.92M | $-8.97M | $-5.59M | $-6.35M | $-6.86M | $-8.16M | $-12.38M | $-12.21M | $-13.14M | $-7.41M | $-15.02M | $-13.14M | $-11.27M | $-7.27M | $-6.89M | $-3.43M | $-3.76M | $-3.76M | $-5.63M | $-5.63M | $-1.71M | $-1.60M | $-3.92M | $-3.31M |
| Low Forecast | $-1.82M | $-2.07M | $-2.13M | $-2.63M | $-2.75M | $-3.21M | $-3.92M | $-13.46M | $-5.59M | $-6.35M | $-6.86M | $-12.23M | $-12.38M | $-12.21M | $-13.14M | $-11.12M | $-15.02M | $-13.14M | $-11.27M | $-10.91M | $-6.89M | $-5.14M | $-3.76M | $-3.76M | $-5.63M | $-5.63M | $-2.56M | $-2.41M | $-5.88M | $-4.96M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.34% | 0.62% | 0.38% | -0.05% | 0.63% | 1.00% | 0.60% | 0.74% | 0.63% | 0.65% | 0.88% | 1.00% | 0.90% | 1.02% | 0.77% | 0.66% | 1.33% | 1.33% | 1.00% | 1.00% |
Aspira Women's Health's average Quarter net income forecast for Dec 22 is $-12.38M, with a range of $-12.38M to $-12.38M. AWH's average Quarter net income forecast represents a -2231.52% decrease compared to the company's last Quarter net income of $581.00K (Sep 22).
Aspira Women's Health SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 8 | 8 | 8 | 8 | 10 | 10 | 20 | 10 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $5.18M | $5.73M | $5.80M | $8.70M | $7.78M | $8.86M | $8.51M | $8.92M | $7.30M | $5.62M | $5.57M | $4.12M | $3.68M | $3.85M | $4.31M | $3.62M | $2.54M | $2.43M | $3.94M | $3.62M |
| Avg Forecast | $18.93M | $16.67M | $15.44M | $13.51M | $10.84M | $9.69M | $9.59M | $8.99M | $8.89M | $10.21M | $9.82M | $8.97M | $7.89M | $8.60M | $8.42M | $6.87M | $6.49M | $5.61M | $5.79M | $4.80M | $4.57M | $3.95M | $14.74M | $13.33M | $11.23M | $8.07M | $1.71M | $1.91M | $1.77M | $3.34M |
| High Forecast | $18.93M | $16.67M | $15.44M | $13.51M | $10.84M | $9.69M | $9.59M | $8.99M | $8.89M | $10.21M | $9.82M | $8.97M | $7.89M | $8.60M | $8.42M | $6.87M | $6.49M | $5.61M | $5.79M | $4.80M | $4.57M | $3.95M | $14.74M | $13.33M | $11.23M | $8.07M | $2.05M | $2.29M | $2.13M | $4.00M |
| Low Forecast | $18.93M | $16.67M | $15.44M | $13.51M | $10.84M | $9.69M | $9.59M | $8.99M | $8.89M | $10.21M | $9.82M | $8.97M | $7.89M | $8.60M | $8.42M | $6.87M | $6.49M | $5.61M | $5.79M | $4.80M | $4.57M | $3.95M | $14.74M | $13.33M | $11.23M | $8.07M | $1.37M | $1.53M | $1.42M | $2.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.53% | 0.64% | 0.73% | 1.01% | 0.92% | 1.29% | 1.31% | 1.59% | 1.26% | 1.17% | 1.22% | 1.04% | 0.25% | 0.29% | 0.38% | 0.45% | 1.49% | 1.27% | 2.22% | 1.08% |
Aspira Women's Health's average Quarter SG&A projection for Sep 23 is $10.21M, based on 1 Wall Street analysts, with a range of $10.21M to $10.21M. The forecast indicates a 97.18% rise compared to AWH last annual SG&A of $5.18M (Jun 23).
Aspira Women's Health EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 8 | 8 | 8 | 8 | 10 | 10 | 20 | 10 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-0.00 | $-0.69 | $-0.04 | $0.01 | $-0.07 | $-0.08 | $-0.08 | $-0.09 | $-0.06 | $-0.05 | $-0.58 | $-0.04 | $-0.03 | $-0.04 | $-0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.09 | $-0.10 |
| Avg Forecast | $-0.14 | $-0.17 | $-0.17 | $-0.21 | $-0.22 | $-0.26 | $-0.31 | $-0.33 | $-0.45 | $-0.51 | $-0.55 | $-0.75 | $-0.99 | $-0.97 | $-1.05 | $-1.20 | $-1.20 | $-1.05 | $-0.90 | $-2.60 | $-0.55 | $-0.60 | $-0.30 | $-0.30 | $-0.45 | $-0.45 | $-0.03 | $-0.03 | $-0.09 | $-0.10 |
| High Forecast | $-0.14 | $-0.17 | $-0.17 | $-0.21 | $-0.22 | $-0.26 | $-0.31 | $-0.33 | $-0.45 | $-0.51 | $-0.55 | $-0.75 | $-0.99 | $-0.97 | $-1.05 | $-1.20 | $-1.20 | $-1.05 | $-0.90 | $-2.60 | $-0.55 | $-0.60 | $-0.30 | $-0.30 | $-0.45 | $-0.45 | $-0.02 | $-0.02 | $-0.07 | $-0.08 |
| Low Forecast | $-0.14 | $-0.17 | $-0.17 | $-0.21 | $-0.22 | $-0.26 | $-0.31 | $-0.33 | $-0.45 | $-0.51 | $-0.55 | $-0.75 | $-0.99 | $-0.97 | $-1.05 | $-1.20 | $-1.20 | $-1.05 | $-0.90 | $-2.60 | $-0.55 | $-0.60 | $-0.30 | $-0.30 | $-0.45 | $-0.45 | $-0.04 | $-0.04 | $-0.11 | $-0.12 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.00% | 0.92% | 0.04% | -0.01% | 0.07% | 0.07% | 0.07% | 0.09% | 0.07% | 0.02% | 1.05% | 0.07% | 0.10% | 0.13% | 0.13% | 0.11% | 1.67% | 1.67% | 1.00% | 1.00% |
According to 1 Wall Street analysts, Aspira Women's Health's projected average Quarter EPS for Dec 22 is $-0.99, with a low estimate of $-0.99 and a high estimate of $-0.99. This represents a -19885.00% decrease compared to AWH previous annual EPS of $0.01 (Sep 22).
Aspira Women's Health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LMDX | LumiraDx | $0.02 | $1.50 | 7400.00% | Buy |
| DRIO | DarioHealth | $1.00 | $10.75 | 975.00% | Buy |
| STIM | Neuronetics | $0.91 | $8.00 | 779.12% | Buy |
| AWH | Aspira Women's Health | $0.85 | $3.30 | 288.24% | Buy |
| GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
| XGN | Exagen | $2.72 | $6.00 | 120.59% | Buy |
| BDSX | Biodesix | $1.63 | $3.00 | 84.05% | Buy |
| RDNT | RadNet | $68.36 | $69.00 | 0.94% | Buy |
| OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |
AWH Forecast FAQ
Is Aspira Women's Health a good buy?
Yes, according to 2 Wall Street analysts, Aspira Women's Health (AWH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of AWH's total ratings.
What is AWH's price target?
Aspira Women's Health (AWH) average price target is $3.3 with a range of $3.3 to $3.3, implying a 285.33% from its last price of $0.856. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Aspira Women's Health stock go up soon?
According to Wall Street analysts' prediction for AWH stock, the company can go up by 285.33% (from the last price of $0.856 to the average price target of $3.3), up by 285.33% based on the highest stock price target, and up by 285.33% based on the lowest stock price target.
Can Aspira Women's Health stock reach $1?
AWH's average twelve months analyst stock price target of $3.3 supports the claim that Aspira Women's Health can reach $1 in the near future.
What are Aspira Women's Health's analysts' financial forecasts?
Aspira Women's Health's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $11.15M (high $11.15M, low $11.15M), average EBITDA is $-19.699M (high $-17.476M, low $-21.923M), average net income is $-21.104M (high $-18.861M, low $-23.347M), average SG&A $39.12M (high $39.12M, low $39.12M), and average EPS is $-1.123 (high $-1.123, low $-1.123). AWH's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $18.4M (high $18.4M, low $18.4M), average EBITDA is $-18.395M (high $-18.395M, low $-18.395M), average net income is $-8.638M (high $-8.638M, low $-8.638M), average SG&A $64.55M (high $64.55M, low $64.55M), and average EPS is $-0.69 (high $-0.69, low $-0.69).
Did the AWH's actual financial results beat the analysts' financial forecasts?
Based on Aspira Women's Health's last annual report (Dec 2022), the company's revenue was $8.18M, which missed the average analysts forecast of $9.06M by -9.63%. Apple's EBITDA was $-38.237M, beating the average prediction of $-16.285M by 134.80%. The company's net income was $-21.575M, missing the average estimation of $-47.003M by -54.10%. Apple's SG&A was $31.13M, missing the average forecast of $31.78M by -2.04%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-4.214 by -95.49%. In terms of the last quarterly report (Jun 2023), Aspira Women's Health's revenue was $2.49M, missing the average analysts' forecast of $2.8M by -11.03%. The company's EBITDA was $-4.321M, beating the average prediction of $-2.8M by 54.33%. Aspira Women's Health's net income was $-2.317M, missing the average estimation of $-6.864M by -66.24%. The company's SG&A was $5.18M, missing the average forecast of $9.82M by -47.30%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $-0.548 by -99.95%